von Schulthess GK - Search Results

1

Non-invasive assessment of tumour cell proliferation with positron emission tomography and [76Br]bromodeoxyuridine.

Böni R, Bläuenstein P, Dummer R, von Schulthess GK, Schubiger PA, Steinert HC. Böni R, et al. Among authors: von schulthess gk. Melanoma Res. 1999 Dec;9(6):569-73. doi: 10.1097/00008390-199912000-00005. Melanoma Res. 1999. PMID: 10661767

2

123I-iomazenil: a quantitative study of the central benzodiazepine receptor distribution.

Haldemann RC, Bicik I, Pfeiffer A, Wieser HG, Hasler PH, Schubiger P, von Schulthess GK. Haldemann RC, et al. Among authors: von schulthess gk. Nuklearmedizin. 1992 Jun;31(3):91-7. Nuklearmedizin. 1992. PMID: 1322533

3

[Positron-emission tomography (PET) in the evaluation of metabolic processes in the myocardium].

Haubold-Reuter B, Haldemann R, Amann F, Turina J, Reist W, Leenders K, von Schulthess GK. Haubold-Reuter B, et al. Among authors: von schulthess gk. Schweiz Med Wochenschr. 1992 Jan 8;122(1-2):14-21. Schweiz Med Wochenschr. 1992. PMID: 1594901 Review. German.

4

Radioimmuno positron emission tomography with monoclonal antibodies: a new approach to quantifying in vivo tumour concentration and biodistribution for radioimmunotherapy.

Westera G, Reist HW, Buchegger F, Heusser CH, Hardman N, Pfeiffer A, Sharma HL, von Schulthess GK, Mach JP. Westera G, et al. Among authors: von schulthess gk. Nucl Med Commun. 1991 May;12(5):429-37. Nucl Med Commun. 1991. PMID: 2067747

5

Regional quantitative noninvasive assessment of cerebral perfusion and function with N-isopropyl-[123I]p-iodoamphetamine.

von Schulthess GK, Ketz E, Schubiger PA, Bekier A. von Schulthess GK, et al. J Nucl Med. 1985 Jan;26(1):9-16. J Nucl Med. 1985. PMID: 3965658 Free article.

6

Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.

Steinert HC, Huch Böni RA, Buck A, Böni R, Berthold T, Marincek B, Burg G, von Schulthess GK. Steinert HC, et al. Among authors: von schulthess gk. Radiology. 1995 Jun;195(3):705-9. doi: 10.1148/radiology.195.3.7753998. Radiology. 1995. PMID: 7753998

7

[Positron-emission tomography (PET)--basic considerations].

von Schulthess GK, Westera G, Schubiger PA. von Schulthess GK, et al. Schweiz Rundsch Med Prax. 1993 Aug 24;82(34):901-4. Schweiz Rundsch Med Prax. 1993. PMID: 8372293 German.

8

Anti-melanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma.

Böni R, Huch Böni RA, Steinert H, Dummer R, Burg G, von Schulthess GK. Böni R, et al. Among authors: von schulthess gk. Dermatology. 1995;191(2):119-23. doi: 10.1159/000246528. Dermatology. 1995. PMID: 8520057 Clinical Trial.

9

Early detection of melanoma metastasis using fludeoxyglucose F 18 positron emission tomography.

Böni R, Huch-Böni RA, Steinert H, von Schulthess GK, Burg G. Böni R, et al. Among authors: von schulthess gk. Arch Dermatol. 1996 Aug;132(8):875-6. doi: 10.1001/archderm.1996.03890320023003. Arch Dermatol. 1996. PMID: 8712836 No abstract available.

10

Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations.

Engel H, Steinert H, Buck A, Berthold T, Huch Böni RA, von Schulthess GK. Engel H, et al. Among authors: von schulthess gk. J Nucl Med. 1996 Mar;37(3):441-6. J Nucl Med. 1996. PMID: 8772641 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters